Promoting tumour apoptosis, diminishing necrosis and enhancing acute inflammation in the tumour microenvironment are novel treatment strategies. Perhaps the most tractable target for therapy is ...
More information: Tom Thomas et al, A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease, Nature Immunology (2024). DOI: 10.1038/s41590-024-01994-8 ...
A recent meta-analysis published in JAMA Neurology has revealed that tumor necrosis factor (TNF) inhibitors, widely used in treating autoimmune diseases, may increase the risk of ...